miR-665 is significantly upregulated in breast cancer tissues and promotes cancer cell proliferation, invasion, and metastasis by inhibiting NR4A3 to activate the MEK signaling pathway, thereby functioning as an oncomiR in breast cancer progression (Zhao et al., 2019). This evidence concerns the gene MAP2K7 and breast carcinoma.